Venn Life Sciences appoints Gracielle Beijerbacht-Schutjens to the Board as Executive Director

– IRELAND – Venn Life Sciences Holdings Plc (AIM: VENN), a growing Clinical Research Organisation (CRO) providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, announces the appointment of Gracielle Anna Maria Beijerbacht-Schutjens to the Board as an Executive Director with immediate effect.…